Member Info for qweqweqwe

Does anyone know of any other questionable shares like STAF?

I’m glad I’m out of this slow car crash with a loss but I think I’ll have a better chance make the loss back shorting this stock.

You have to be a client of UBS for that research note, so I guess it’s not 100% free.

I take broker notes and research with a pinch of salt, but I prefer reading them as sometimes they shed light on something that you haven’t thought of I.e the cost savings of sharing masts. But all in all, a research from a reputable financial institution has more credibility than someone spewing their tripe on a free bulletin board.

In any case, please do your own research and never invest what you can’t afford to loose.

My personal favourite advice would be to aim for slow financial success rather than get rich quick scheme, as the latter is never good for your peace of mind or your portfolio suffering volatility.

Send me your e-mail address and I’ll share the research.

Just re-read UBS analysts research on this share and they are very bullish and that’s excluding the potential masts share that will save them almost 500M per year.

Although the share is down from 52 week high but this is a long term play and is in the growth sector and the coming of 5G and IoT will accelerate the growth and with a nudge from consumers wanting to upgrade who normally don’t to utilise 5G.

Although I’m at a paper loss but don’t hesitate holding this for a long time while picking up the divi while I wait.

I still don’t understand how comes the II’s rubber stamped the bonus? Surely they care about their clients funds being eroded for the last 5 years?

Does anyone know when is the next update?

Perhaps the BoD has short position open.

Warren Buffett is on the lookout to buy a company outright as he’s issuing long term bond in GBP and EUR. Although this company might be a small minnow for him but he has a stake in a UK utility firm already. CNA shareholders will really benefit from Berkshire Hathaway’s watchful management and their piles of cash will be a marriage made in heaven.

I think most experienced investors have wised up and no longer partaking in this rigged share market with HFT, Algo trading and shorting in cahoots, with journalists on their payroll.

The current quality of BoD in FTSE are in it for themselves by highly leveraging the companies whilst giving SH a token dividend to shut them up.

I wouldn’t be surprised to see a claim similar to PPI unearthed in 5 to 10 years time with Hedge funds, Money Managers guilty of malpractice or even brokers selling investors trading data to Market Makers.

It’s incredible to see a share drop from 1300 to 150, which is almost 90% drop. Nowadays these drops are highly volatile especially when shorting and spread betting is in play.

Although I’m not happy about the additional 8M contingent liabilities but am glad that all bad news is out of the way and BoD were proactive in dealing with the debt covenant rather than leave SH in the dark or on speculation

Agree with Jam. If people still want to hold this share then perhaps they can sell now and buy it back later, but obviously DYOR

Even if there was a light at the end of the tunnel, you still have a problem of having an inexperienced CEO with track record of rookie mistakes. They need to replace him with someone who is an American through and through to closely collaborate with the FDA.

The fact that they have more employees on board, this will translate into faster cash burn and thus resulting in more raise and dilution if they can get someone to raise

The main reason I exited is due to the track record of BoD incompetence.

If they were in constant communication with FDA and collaborated with trial design then why do we have a surprise liver toxicity that wasn’t dealt with. Why no AdCom, why was the NASDAQ listing a total shambles, they didn’t plan for a possible CRL response (just like Brexit contingency) and make the most of the Type A Meeting and above all they didn’t plan for option 3 response and not leaving enough cash.

With the above track record in mind, it would be fair to replace the BoD and start again or sell the company and let a competent BoD do a better job to push this over the line. However, even then, there’s no guarantee as the FDA May come up with other concerns.

For that reason I’ve sold everything for an obvious loss.

I still don’t feel comfortable GL not having skin in the game and not putting his own money on the line. He mentioned having options but that’s free money from the company if things works out.

Even if we had approval, I would have never invested in any company where these directors had any management influence.

Good for you Chancers and anyone else who wants to exit and play into the MM’s hands.

Agreed, at this level LTH like me don’t care. I’m in this until the bitter or sweet end.